Clinical Characteristics in Congenital Cataract Eyes

• Sponsor: yin ying zhao (Other)
• Overall Status: Completed
• CT.gov ID: NCT03905044
• Collaborator: (none)
• Enrollment: 239
• Actual Duration (Months): 92

Study Details

Study Description

Brief Summary

This study involved children with congenial cataract eyes, who underwent cataract surgeries at the Eye Hospital of Wenzhou Medical University (Hangzhou, China). All medical records were reviewed for primary diagnosis. All surgeries were performed by one experienced surgeon (Z.Y.E) and videos were collected for reviews in details. the clinical data after the surgery were also recorded for further analysis.

Condition or Disease	Intervention/Treatment	Phase
Congenital Cataract	Other: eyes with congenital cataracts

Study Design

• Study Type: Observational
• Actual Enrollment: 239 participants
• Observational Model: Other
• Time Perspective: Retrospective
• Official Title: Clinical Characteristics of Three Pathological Types of Posterior Capsule Abnormality in Congenital Cataract Eyes
• Actual Study Start Date: Jan 1, 2011
• Actual Primary Completion Date: Aug 31, 2018
• Actual Study Completion Date: Aug 31, 2018

Arms and Interventions

Arm	Intervention/Treatment
CC eyes with congenital cataracts	Other: eyes with congenital cataracts; observation

Outcome Measures

Primary Outcome Measures

1. complication rate [3 months]

   the complication occurrent rate

Eligibility Criteria

Criteria

• Ages Eligible for Study: 1 Day to 18 Years
• Sexes Eligible for Study: All
• Accepts Healthy Volunteers: No

Inclusion Criteria:

• children with congenital cataracts who underwent cataract surgeries at the Eye Hospital of Wenzhou Medical University (Hangzhou, China)

Exclusion Criteria:

• ocular trauma

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

• yin ying zhao

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.

• Responsible Party: yin ying zhao, Clinical professor, Wenzhou Medical University
• ClinicalTrials.gov Identifier: NCT03905044
• Other Study ID Numbers: DXX-CC
• First Posted: Apr 5, 2019
• Last Update Posted: Apr 5, 2019
• Last Verified: Apr 1, 2019

• Individual Participant Data (IPD) Sharing Statement: No
• Plan to Share IPD: No
• Studies a U.S. FDA-regulated Drug Product: No
• Studies a U.S. FDA-regulated Device Product: No
• Additional relevant MeSH terms: Cataract

Study Results

No Results Posted as of Apr 5, 2019